# Aytu Biopharma, Inc: Form 8-K, filed Jun 6, 2025

- Company: [Aytu Biopharma, Inc](/companies/aytu.md) (CIK 1385818)
- Form: 8-K
- Filed: 2025-06-06
- Accepted by EDGAR: Jun 6, 2025, 16:07 ET
- Period: 2025-06-05
- Accession: 0001437749-25-019718
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1385818/000143774925019718/aytu20250523c_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1385818/000143774925019718/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.01: Completion of an acquisition or disposition
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1385818/000143774925019718/aytu20250523c_8k.htm

Filed Jun 6, 2025.
Source: SEC EDGAR, the filing index for accession 0001437749-25-019718. Last ingested by Listed: Oct 27, 2026, 16:32 ET. No prices; not investment advice.